Pamrevlumab Uses, Dosage, Side Effects and more
Pamrevlumab is under investigation in clinical trial NCT00913393 (Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy).
| Attribute | Details |
|---|---|
| Trade Name | Pamrevlumab |
| Generic | Pamrevlumab |
| Pamrevlumab Other Names | Pamrevlumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
